These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2480993)

  • 1. Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants.
    Trigg ME; de Alarcon P; Rumelhart S; Holida M; Giller R
    J Biol Response Mod; 1989 Dec; 8(6):603-13. PubMed ID: 2480993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
    Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
    Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
    Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
    O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
    Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
    [No Abstract]   [Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis.
    Imashuku S; Naya M; Yamori M; Nakabayashi Y; Hojo M; Kihara A; Tabata Y; Akioka C; Hibi S; Todo S
    Bone Marrow Transplant; 1997 May; 19(10):1059-60. PubMed ID: 9169655
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
    Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
    Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
    Gharpure V; Rubin L; Amlin J; Emanuel D; Schroeder W; Davidson A; Hromas R; Cornetta K
    Bone Marrow Transplant; 1996 Jul; 18(1):221-4. PubMed ID: 8832021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated central nervous system Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Watanabe A; Yoshida S; Kasahara Y; Takachi T; Ogawa A; Asami K
    Pediatr Blood Cancer; 2011 May; 56(5):871-2. PubMed ID: 21370426
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
    Porter DL; Orloff GJ; Antin JH
    Transplant Sci; 1994 Sep; 4(1):12-4; discussion 14-6. PubMed ID: 7804691
    [No Abstract]   [Full Text] [Related]  

  • 19. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?
    Mackinnon S; Papadopoulos EB; Carabasi MH; Reich L; Collins NH; O'Reilly RJ
    Bone Marrow Transplant; 1995 Apr; 15(4):591-4. PubMed ID: 7655386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
    Wang LC; Lu MY; Yu J; Jou ST; Chiang IP; Lin KH; Lin DT
    Bone Marrow Transplant; 2000 Oct; 26(8):893-7. PubMed ID: 11081391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.